VICTORY CAPITAL MANAGEMENT INC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 167 filers reported holding REATA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 2.04 and the average weighting 0.5%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$21,608,485
+47.0%
211,931
+31.1%
0.02%
+41.2%
Q1 2023$14,700,127
+4900.0%
161,682
+1283.1%
0.02%
Q3 2022$294,000
-12.2%
11,690
+5.9%
0.00%
Q2 2022$335,000
+19.2%
11,039
-0.1%
0.00%
Q1 2022$281,000
-4.1%
11,053
-0.7%
0.00%
Q4 2021$293,000
-76.9%
11,126
-11.7%
0.00%
-100.0%
Q3 2021$1,268,000
-29.7%
12,605
-1.0%
0.00%
-50.0%
Q2 2021$1,803,000
+35.9%
12,737
-4.3%
0.00%
+100.0%
Q1 2021$1,327,000
-23.2%
13,314
-4.7%
0.00%
-50.0%
Q4 2020$1,727,000
+13.8%
13,972
-10.3%
0.00%0.0%
Q3 2020$1,517,000
-54.6%
15,574
-27.3%
0.00%
-60.0%
Q2 2020$3,343,000
-45.2%
21,424
-49.3%
0.01%0.0%
Q1 2020$6,098,000
+38.7%
42,252
+96.5%
0.01%0.0%
Q4 2019$4,396,000
+100.3%
21,505
-21.3%
0.01%
+66.7%
Q3 2019$2,195,000
+3498.4%
27,342
+4139.1%
0.00%
Q2 2019$61,000
-26.5%
645
-33.3%
0.00%
Q1 2019$83,000
+53.7%
9670.0%0.00%
Q4 2018$54,000
-42.6%
967
-16.0%
0.00%
Q3 2018$94,000
+168.6%
1,151
+15.1%
0.00%
Q2 2018$35,000
+66.7%
1,0000.0%0.00%
Q1 2018$21,000
-97.0%
1,000
-95.9%
0.00%
-100.0%
Q4 2017$698,000
+2.2%
24,670
+12.2%
0.00%
-50.0%
Q3 2017$683,000
+2.7%
21,980
+4.5%
0.00%0.0%
Q2 2017$665,000
+37.7%
21,030
-1.4%
0.00%
+100.0%
Q1 2017$483,00021,3200.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders